Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Cardiologist
MBBS (RMC), FCPS (Medicine), MCPS (Medicine), Dip-Card (UK), MCPS (Cardiology)
Cardiologist
MBBS (RMC), FCPS (Medicine), MCPS (Medicine), Dip-Card (UK), MCPS (Cardiology)
Rheumatologist
MBBS, FCPS (Medicine), Fellowship FCPS in Rhematology
Rheumatologist
MBBS, FCPS (Medicine), Fellowship FCPS in Rhematology
Consultant Physician
MBBS, M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Consultant Physician
MBBS, M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Nephrologist
MBBS, Diplomate American Board Nephrology
Internal Medicine Specialist
MBBS, MRCP (UK), PCRC, Kidney dialysis certified
Internal Medicine Specialist
MBBS, MRCP (UK), PCRC, Kidney dialysis certified
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures